InBody Co.Ltd

InBody Co.Ltd

041830 · KQ · Healthcare / Healthcare Equipment & Supplies

38,800.00KRW-850.00 (-2.14%)

Price History

Full chart

Market Stats

Previous Close39,650.00
Open39,650.00
Day Range38,150.00 – 40,850.00
52-Week Range25,656.06 – 73,500.00
Volume55.18K
Market Cap688.68B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.81%
Beta0.69
50-Day Avg57,925.00
200-Day Avg42,041.25

About

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Equipment & Supplies
  • CEODr. Ki-Chul Cha
  • Employees266
  • HeadquartersInBody Building, Seoul, South Korea, 06106, Korea
  • Websitehttps://www.inbody.com/global

Leadership

  • Dr. Ki-Chul ChaChief Exec. Officer · b. 1958
  • Yoon-Sun ShinManaging Director
  • Ju-Sik ShinExec. Officer

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue31.56B33.23B36.79B48.94B68.95B79.85B93.25B99.64B117.06B107.12B137.84B160.00B170.35B204.46B233.95B
Growth (%)-+5.29%+10.70%+33.04%+40.88%+15.81%+16.79%+6.84%+17.49%-8.49%+28.67%+16.08%+6.47%+20.03%+14.42%
Cost of Revenue9.43B9.17B10.32B14.09B19.52B22.01B23.79B26.70B30.80B29.67B36.52B38.93B37.90B46.24B52.94B
Gross Profit---34.17B49.43B57.84B69.46B72.93B86.26B77.45B101.32B121.07B132.45B158.23B181.01B
Gross Margin---69.81%71.69%72.43%74.49%73.20%73.69%72.30%73.51%75.67%77.75%77.39%77.37%
Operating Expense---24.07B29.42B35.99B44.56B49.25B58.83B58.35B65.47B80.37B94.11B121.49B144.26B
Operating Income3.85B5.00B6.50B10.10B20.01B21.85B24.90B23.68B27.43B19.10B35.85B40.70B38.35B36.74B36.75B
Operating Margin12.21%15.05%17.67%20.63%29.02%27.36%26.70%23.76%23.43%17.83%26.01%25.44%22.51%17.97%15.71%
EBITDA-----------47.99B50.89B51.31B47.72B
EBITDA Margin-----------29.99%29.87%25.09%20.40%
Net Income5.53B5.64B6.19B8.88B17.31B16.99B19.32B19.67B20.43B17.52B34.03B33.82B36.72B33.14B30.63B
Net Income Margin17.54%16.98%16.84%18.14%25.11%21.27%20.72%19.74%17.45%16.35%24.69%21.13%21.56%16.21%13.09%
R&D4.41B-2.71B3.50B4.88B5.38B7.25B5.21B5.24B5.80B8.06B8.78B9.31B11.17B11.18B
R&D as % of Total Revenue13.98%-7.37%7.16%7.08%6.73%7.78%5.23%4.48%5.41%5.85%5.49%5.47%5.46%4.78%
Interest Expense00000000120.42M124.47M103.50M121.99M329.51M384.13M504.32M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.10%0.12%0.08%0.08%0.19%0.19%0.22%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets43.85B48.16B53.67B63.17B82.53B97.06B112.02B131.69B154.90B166.15B203.76B242.67B274.46B305.82B361.06B
Total Liabilities1.70B2.03B2.11B3.56B6.21B4.76B5.55B7.30B15.21B16.09B20.03B27.41B24.62B31.91B41.27B
Total Equity41.83B46.13B51.56B59.58B76.32B92.30B106.48B124.39B139.69B150.06B183.73B215.26B248.77B272.97B317.85B
Cash4.63B4.57B4.40B4.72B217.89M4.78B9.60B9.63B14.42B16.98B18.56B21.56B22.29B31.05B52.37B
Total Debt--------2.96B2.81B-----

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.50B4.36B6.99B10.26B11.18B18.24B18.58B17.70B24.21B28.50B30.35B30.42B38.69B28.58B35.78B
Investing Cash Flow----9.11B-9.68B-12.61B-13.07B-17.68B-12.02B-16.34B-25.12B-22.02B-32.29B-5.71B-
Financing Cash Flow----518.22M-816.76M-1.09B-4.21B-1.65B-7.42B-9.18B-4.27B-5.25B-6.16B-15.11B-
Capital Expenditure2.41B812.05M9.26B1.47B7.55B8.41B5.31B40.86B3.08B1.69B11.45B6.02B7.64B7.55B7.42B
Free Cash Flow---------26.58B18.51B24.40B31.04B21.03B28.36B
Dividends Paid544.51M544.51M544.51M544.51M816.76M1.09B1.36B1.62B1.62B1.86B1.82B2.61B3.91B4.56B5.04B
FCF to OCF---------93.27%61.00%80.22%80.25%73.58%79.26%
Dividend Paid to FCF---------7.01%9.85%10.68%12.59%21.69%17.79%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Nov 10, 2014Feb 10, 2015May 7, 2015Aug 17, 2015Nov 16, 2015Mar 15, 2016May 10, 2016Aug 16, 2016Nov 14, 2016Mar 31, 2017May 10, 2017Aug 11, 2017Nov 14, 2017Mar 20, 2018May 14, 2018Aug 14, 2018Nov 14, 2018Feb 28, 2019May 15, 2019Aug 12, 2019Nov 11, 2019Mar 2, 2020May 13, 2020Aug 14, 2020Nov 16, 2020May 17, 2021Aug 17, 2021Nov 15, 2021Mar 16, 2022May 16, 2022Aug 11, 2022Nov 14, 2022Feb 23, 2023May 15, 2023Aug 10, 2023Nov 14, 2023Mar 26, 2024May 16, 2024Aug 14, 2024Nov 12, 2024May 8, 2025Aug 12, 2025Nov 12, 2025Feb 27, 2026May 6, 2026Aug 18, 2026
EPS Estimate-----------------------29.80-269.66253.38317.77400.00360.71362.96390.77362.70340.40409.22502.90397.34370.96399.56351.59355.67487.34249.49--48.00142.00-406.00404.00------------------
EPS Actual50.22146.40135.0181.0543.50183.81104.0053.85109.39104.67124.7867.75105.0498.6429.1284.98184.0988.26105.4477.26247.68183.89164.0656.00278.72280.00399.00314.00356.00340.00228.00324.00179.00364.00427.00462.00273.00447.00444.00296.00402.00511.00373.00244.24376.0031.00453.00771.00640.00543.00659.00658.56662.44706.61455.19794.37540.83925.23558.57675.31637.24570.55677.40610.87790.64480.871224.251060.93
Surprise-----------------------87.92%-3.83%57.47%-1.19%-11.00%-5.74%-37.18%-17.09%-50.65%6.93%4.34%-8.13%-31.29%20.50%11.12%-15.81%13.03%4.85%49.51%---35.42%219.01%-57.64%34.41%------------------
Timing----------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap688.68B
Enterprise Value572.92B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.63
Price / Book2.06
Revenue (TTM)154.93B
Gross Profit (TTM)100.92B
EBITDA43.01B
Profit Margin23.54%
Operating Margin24.48%
Return on Equity1191.01%
Return on Assets10.90%
Shares Outstanding13.48M
Shares Float10.42M
Beta0.69
Dividend Yield1.81%
Dividend Rate0.00
Payout Ratio16.87%

Dividends

20261×
600.00Mar 30, 2026
20251×
400.00Mar 28, 2025
20231×
350.00Dec 27, 2023
20221×
300.00Dec 28, 2022
20211×
200.00Dec 29, 2021
20201×
140.00Dec 29, 2020
20191×
140.00Dec 27, 2019
20181×
120.00Dec 27, 2018
20171×
120.00Dec 27, 2017
20161×
100.00Dec 28, 2016
20151×
80.00Dec 29, 2015
20141×
60.00Dec 29, 2014
20131×
40.00Dec 27, 2013
20121×
40.00Dec 27, 2012
20111×
40.00Dec 28, 2011
20101×
40.00Dec 29, 2010
20091×
40.00Dec 29, 2009
20081×
40.00Dec 29, 2008
20071×
25.00Dec 27, 2007
20051×
20.66Dec 28, 2005
20041×
22.73Dec 29, 2004
20031×
41.32Dec 29, 2003
20021×
41.32Dec 27, 2002
20011×
20.66Dec 27, 2001

Stock Splits

  • Apr 23, 20102:1
  • Dec 28, 200511:10
  • Dec 29, 200411:10